Shaheerr

Busy pushing onco data solutions..

[Shaheerr @shaheerrr_]

@omar_or_ahmed @sullyai That describes part of the market. Not every company took that route. Some of us built the hard part first. Deep domain data, real workflow, a durable foundation beneath the AI layer. That actually led to trust from major pharma, profitability, and no need to raise. 😉

[LARVOL @Larvol]

European Lung Cancer Congress (ELCC 2026): Conference Round-Up

Explore more insights and conference data from #ELCC26 👉 https://t.co/PuWKbMIQiA

#LARVOL #ELCC2026 #LungCancer #LCSM #NSCLC #SCLC #ESSCLC #CancerResearch #CancerData #Oncology #OncologyInsights #ClinicalTrials | @BrunoLarvol | @Jud_Prz

[Shaheerr @shaheerrr_]

Does this make AI choice easier or harder?
Or does it just force us to admit what kind of answers we actually want under pressure?

#Ai #Trump

[LARVOL @Larvol]

Our abstract on Network Meta Analysis has been accepted for presentation at @myESMO Breast Cancer Congress 2026.

We’re proud to contribute to the global breast cancer conversation and to share insights shaped by real-world data and AI-driven analysis.

Grateful to the entire team who made this possible. More details to follow soon.

Get data-driven and real-time insights with CLIN 👉 https://t.co/ct6tMIQHii

#LARVOL #CancerResearch #CancerData #Oncology #OncologyInsights #ClinicalTrials #BreastCancer #BCSM #ESMOBreast26 | @brunolarvol | @Jud_Prz | @MedinDarko

[LARVOL @Larvol]

2025 in review at LARVOL ❤️

From global oncology conferences and real-time trial insights to meaningful collaborations and growing together as a global team, this year was about learning, building, and delivering real-time, actionable insights from oncology data.

Thank you for being a part of @LARVOL's 2025!

#LARVOL #CancerResearch #CancerData #Oncology #OncologyInsights #ClinicalTrials

[Shaheerr @shaheerrr_]

2025: Look back and thank God.
2026: Look ahead and trust God.

[Shaheerr @shaheerrr_]

@brunolarvol @Larvol Thanks Bruno!

[Shaheerr @shaheerrr_]

made it to the #timessquare ⚡️

[ONCO BRUNO @brunolarvol]

And top @LARVOL tigers. Including @one_interrobang and @shaheerrr_ (HBD BTW !!)

[Dr. Robert F. Siegmund, MBA @robertfsiegmund]

This @LinkedIn article of mine will be of interest to fellow #oncology #AI practitioners. I generated a list of most anticipated trials @myESMO congress with a combination of AI-driven social media listening (Data from @Larvol CLIN) & prompting AI models: https://t.co/3O2GOnJr1T

[Shaheerr @shaheerrr_]

We’ve been running LLMs on oncology trial data from CLIN, and this round focused on BsAb trials gaining momentum ahead of ESMO. Most models flagged the usual. If you’re tracking trials too i would love to exchange notes.

#LLM #ESMO25 #LARVOL

[Shaheerr @shaheerrr_]

@brunolarvol @mhdfaran @one_interrobang ⚡️

[ONCO BRUNO @brunolarvol]

Here is a transparent look at our process of how we combine oncologist sentiment and trial data to provide curated trial ratings.

#Oncology #ClinicalTrials #LARVOLCLIN #MedTwitter #BuildingInPublic

[ONCO BRUNO @brunolarvol]

Useful data ? What other analytics should we build ?

[Reena Thakur @5Reena_thakur]

June 2025 – FDA Cancer Drug Approvals
👉Datopotamab deruxtecan – EGFR+ NSCLC
👉Tafasitamab-cxix – R/R FL
👉Pembro – Res HNSCC
👉Mitomycin – NMIBC
👉Taletrectinib – ROS1+ NSCLC
👉Darolutamide – mCSPC
#FDA #Oncology #CLIN #Approval #Cancer #CancerDrugs #June2025

[LARVOL @Larvol]

FDA grants accelerated approval to datopotamab deruxtecan-dlnk for EGFR-mutated non-small cell lung cancer

https://t.co/GQYmpI8gnx

Learn more 👇
TROPION-Lung01: https://t.co/cNLjagUKMz
TROPION-Lung05: https://t.co/4aKW54rcBK

#LARVOL #FDAApproval #CancerResearch #Oncology #LungCancer #NSCLC #ClinicalTrials #CancerData #OncologyInsights #TROPIONLung01 #TROPIONLung05

[OncoDaily @oncodaily]

@brunolarvol @OncoAlert @SuyogCancer @shaheerrr_ We would like to inform you that your post has been published on https://t.co/igx4msDtQG. Thank you for sharing.
https://t.co/r7rdEhU9VG

[OncoDaily @oncodaily]

Back to Times Square: Celebrating Oncologists - Bruno Larvol

@brunolarvol

https://t.co/r7rdEhU9VG

#OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedEd #MedNews @CancerWorldmag

[LARVOL @Larvol]

Subcutaneous Isatuximab studies in multiple myeloma from @EHA_Hematology 2025.

Follow us for the latest #EHA2025 updates: https://t.co/GlFVhoEY2I

#LARVOL #Hematology #CancerResearch #Oncology #CancerData #OncologyInsights | @Abdallah81MD | @HadidiSamer | @mtmdphd | @DrOlaLandgren | @RahulBanerjeeMD | @Rfonsi1 | @SuyogCancer

[Shaheerr @shaheerrr_]

@uyargalip @DrMirallas Congratulations! 🩺

[Galip Can Uyar @uyargalip]

Congratulations Oriol! 🎉

Being named one of the Oncology Rising Stars at ASCO 2025 is truly inspiring.
It’s an honor to be working with you — I’m genuinely proud of our collaboration.
Looking forward to your continued success!

#ASCO2025 #OncologyRisingStars #ProudToCollaborate #FutureLeaders

@DrMirallas @LancetRH_Europe @TheLancet @osutcuoglu @OncoAlert @oncodaily @ASCO @VHIO @MDAndersonNews @Xesiloglu